FGFR3 and achondroplasia: The various phenotypes and different levels of severity observed in different ACH mouse models might be caused by the different promoter chosen and various copy numbers of activated FGFR3 in the transgenic models, the different knock-in approaches used in the KI models, and the different genetic backgrounds of the mice assayed.